Multiple Ascending Dose Study of MHS552 in Adults Participants With Systemic Lupus Erythematosus (SLE)

Summary

The purpose of this two-part multiple ascending dose study is to evaluate the safety and tolerability of multiple doses of MHS552 in adults with mild to moderately active Systemic Lupus Erythematosus (SLE). Participants will be treated for 4 or 12 weeks followed by an 8-week follow-up period.

Timeline

Start

2022-03-15

Primary completion

2023-06-04

Completion

2023-06-04

Outcome

Outcome not reported

Stopped (Business): “Sponsor Decision”

Drugs

Indications